Management of optic-hypothalamic gliomas in children: still a challenging problem (Q37004680)

17 August 2017

1 reference

title

Management of optic-hypothalamic gliomas in children: still a challenging problem (English)

1 reference

17 August 2017

Luca Massimi

1 reference

17 August 2017

Tommaso Tufo

series ordinal

1 reference

17 August 2017

Concezio Di Rocco

series ordinal

1 reference

17 August 2017

publication date

1 November 2007

1 reference

Expert Review of Anticancer Therapy

17 August 2017

published in

1 reference

17 August 2017

1 reference

17 August 2017

1 reference

17 August 2017

page(s)

1591-1610

1 reference

Visual loss in childhood.

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Malignant chiasmal glioma: a rare cause of rapid visual loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Involution of diencephalic pilocytic astrocytoma after partial resection. Report of two cases in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Childhood diencephalic pilocytic astrocytoma. A review of seven observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Growth and endocrine disorders in optic glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Diencephalic syndrome and disseminated juvenile pilocytic astrocytomas of the hypothalamic-optic chiasm region

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Late-onset optic pathway tumors in children with neurofibromatosis 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Optic pathway glioma: outcome and prognostic factors in a surgical series

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Optic chiasmatic-hypothalamic glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

21 January 2018

Optic pathway gliomas

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Gliomas of the anterior visual pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Chiasmatic low-grade glioma presenting with sacral intradural spinal metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Management of recurrent pilocytic astrocytoma with leptomeningeal dissemination in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

The biological and clinical behaviour of pilocytic astrocytomas of the optic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

From the archives of the AFIP: pilocytic astrocytoma: radiologic-pathologic correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Visual pathway tumor: a heterogeneous tumor with a variable clinical course

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Development of anaplastic changes in low-grade astrocytomas of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

The 2007 WHO classification of tumours of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Pathology of diencephalic astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Long-term outcome of hypothalamic/chiasmatic astrocytomas in children treated with conservative surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Spontaneous remission of chiasmatic/hypothalamic masses in neurofibromatosis type 1: report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Spontaneous regression of low-grade astrocytomas in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Diffusion MRI in neurofibromatosis type 1: ADC evaluations of the optic pathways, and a comparison with normal individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

A fast visual evoked potential method for functional assessment and follow-up of childhood optic gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Visual pathway glioma: an erratic tumour with therapeutic dilemmas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Spontaneous partial regression of low-grade glioma in children with neurofibromatosis-1: a real possibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Postoperative regression of opticochiasmatic astrocytoma: a case for expectant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Optic pathway/hypothalamic gliomas: a dilemma in management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

When do children with optic pathway tumours need treatment? An oncological perspective in 106 patients treated in a single centre.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Radiation therapy for gliomas of the optic nerve and chiasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Gliomas of the optic nerve or chiasm. Outcome by patients' age, tumor site, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Long-term follow up of 69 patients treated for optic pathway tumours before the chemotherapy era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Analysis of 20 primarily surgically treated chiasmatic/hypothalamic pilocytic astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Dissemination of low grade intracranial astrocytomas in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Metastatic juvenile pilocytic astrocytoma. Case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Tumor volume and growth kinetics in hypothalamic-chiasmatic pediatric low grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Pediatric low-grade gliomas: prognosis with proton magnetic resonance spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

DNA topoisomerase IIalpha expression in optic pathway gliomas of childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Management and outcome of low-grade astrocytomas of the midline in children: a retrospective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Surgery of giant gliomas of chiasma and IIIrd ventricle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Successful high-dose chemotherapy for widespread neuroaxis dissemination of an optico-hypothalamic juvenile pilocytic astrocytoma in an infant: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Carboplatin treatment of progressive optic pathway gliomas to delay radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Optic pathway hypothalamic gliomas in children under three years of age: the role of chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Fractionated stereotactic radiotherapy of optic pathway gliomas: tolerance and long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Management of optic pathway and chiasmatic-hypothalamic gliomas in children with radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Radiation therapy of optico-hypothalamic gliomas (OHG)--radiographic response, vision and late toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part I: Treatment modalities of radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Stereotactically guided conformal radiotherapy for progressive low-grade gliomas of childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Initial management of children with hypothalamic and thalamic tumors and the modifying role of neurofibromatosis-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Prognostic factors for progression of childhood optic pathway glioma: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Long-term outcome in children with gliomas of the anterior visual pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Complete recovery of visual functions after multimodality treatment for intrinsic chiasmatic-hypothalamic astrocytoma--case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Low-grade astrocytomas in children: evolving management strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Optimization of stereotactically-guided conformal treatment planning of sellar and parasellar tumors, based on normal brain dose volume histograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Neuropsychological outcome in children with optic pathway tumours when first-line treatment is chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Brain tumors with symptomatic onset in the first two years of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Management of child optic pathway gliomas: new therapeutical option

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Iodine-125 interstitial irradiation for cerebral gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Neuropsychological functioning after surgery in children treated for brain tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Post-shunt ascites in infants with optic chiasmal hypothalamic astrocytoma: role of ventricular gallbladder shunt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Childhood optic pathway tumors associated with ascites following ventriculoperitoneal shunt placement

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Tolerance of nitrosurea-based multiagent chemotherapy regime for low-grade pediatric gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Carboplatin for the treatment of children with newly diagnosed optic chiasm gliomas: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Successful treatment of childhood pilocytic astrocytomas metastatic to the leptomeninges with high-dose cyclophosphamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Phase II study of carboplatin in children with progressive low-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Chemotherapy in low-grade astrocytoma management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

High response rate to cisplatin/etoposide regimen in childhood low-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Cyclophosphamide for the treatment of progressive low-grade astrocytoma: a Pediatric Oncology Group phase II Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy--results of the first French prospective study for the French Society of Pediatric Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Effectiveness of novel combination chemotherapy, consisting of 5-fluorouracil, vincristine, cyclophosphamide and etoposide, in the treatment of low-grade gliomas in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Phase II trial of temozolomide in patients with progressive low-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Temozolomide in children with progressive low-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Chiasmal gliomas: results of irradiation management in 57 patients and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part II: Treatment-related late toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Vascular malformation with radiation vasculopathy after treatment of chiasmatic/hypothalamic glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Definitive radiation therapy in the management of symptomatic patients with optic glioma. Survival and long-term effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Optic glioma in children: surveillance, resection, or irradiation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Two cases of Gamma Knife radiosurgery for low-grade optic chiasm glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Early outcomes after stereotactic radiosurgery for growing pilocytic astrocytomas in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Suprasellar tumors in children: a review of clinical manifestations and managements

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Neurologic complications of chemotherapy for children with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Late complications in childhood central nervous system tumour survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Candidate mechanisms for chemotherapy-induced cognitive changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Secondary malignancies following cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Therapy-associated solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Optic gliomas. A reanalysis of the University of California, San Francisco experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Management of low-grade gliomas of the optic nerve and chiasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Optic glioma of childhood: clinical, histopathological, and histochemical observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Survival and functional outcome of children with hypothalamic/chiasmatic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Optic gliomas: a retrospective analysis of 50 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Pilocytic and pilomyxoid hypothalamic/chiasmatic astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1591

Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide

21 January 2018

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1200/JCO.1995.13.8.2072

Identifiers

DOI

10.1586/14737140.7.11.1591

1 reference

17 August 2017

1 reference